How to define failure of intradetrusor injections of botulinum toxin A for neurogenic detrusor overactivity.
Camille MailhoBenoît PeyronnetMarianne De SezeAlexia EvenMaire-Aimée Perrouin-VerbeGérard AmarencoEmmanuel Chartier-KastlerLoic Le NormandAndrea ManuntaGilles KarsentyJacques KerdraonAlain RuffionChristian SaussineFrédérique Le BretonBenjamin BernuzEvelyne Castel-LacanalPierre DenysVéronique PhéXavier GaméPublished in: Neurourology and urodynamics (2024)
O and/or a compliance issue and/or persistence of urinary incontinence and/or urgency and/or a number of daily self-catheterizations >8/day and/or efficacy <3 months. This study will help to standardize research on the failure of the intradetrusor botulinum toxin for NDO in clinical practice and clinical research.